Mucormycosis: An emerging challenge in Covid-19 management, Health News, ET HealthWorld - News Summed Up

Mucormycosis: An emerging challenge in Covid-19 management, Health News, ET HealthWorld


Unfortunately some of the Covid-19 treated patients suffer with another fatal infection, Mucormycosis commonly called as – Black Fungus . However, Physicians treating COVID patients are prescribing variable doses of these steroids . Multiple anti-microbial agents are also prescribed to prevent and treat pulmonary infections that may cause pneumonia.Many Covid patients also suffer from comorbid conditions. Looking at dose limiting toxicities, especially nephrotoxicity , the first choice is Liposomal Amphotericin B. (b) Liposomal Amphotericin B in Saline a formulation which is recommended at dose of 1-3 vials per day.


Source: Economic Times May 09, 2021 19:23 UTC



Loading...
Loading...
  

Loading...

                           
/* -------------------------- overlay advertisemnt -------------------------- */